Global mRNA Vaccines Supply, Demand and Key Producers, 2026-2032
The global mRNA Vaccines market size is expected to reach $ 19880 million by 2032, rising at a market growth of 11.6% CAGR during the forecast period (2026-2032).
In 2025, global mRNA vaccine production was about 1.1 billion doses with capacity near 2 billion doses per year; the average revenue per dose is USD 8, and innovator gross margins are around 62%. mRNA vaccines are biologic medicines that use messenger RNA (mRNA) molecules to instruct human cells to produce a harmless piece of a pathogen (such as a viral spike protein), which triggers an immune response without exposing the body to the actual disease. Their supply chain spans multiple specialized layers: upstream raw materials (nucleotides, enzymes, plasmid DNA templates, lipid components for lipid nanoparticles, buffers, and sterile consumables), midstream manufacturing (in-vitro transcription of mRNA, purification, lipid nanoparticle encapsulation, sterile fill-finish, and cold-chain packaging), and downstream distribution and deployment (ultra-cold storage logistics, regulatory release, healthcare delivery, and post-market pharmacovigilance). The ecosystem involves biotech innovators, contract development and manufacturing organizations (CDMOs), lipid and reagent suppliers, cold-chain logistics providers, and healthcare systems, making mRNA vaccines a highly integrated biopharmaceutical supply chain driven by rapid scalability, advanced materials, and stringent quality control.
The mRNA vaccine market is driven by pandemic preparedness policies, rapid platform scalability, and expanding applications beyond infectious diseases into oncology and rare diseases. Government funding, advance purchase agreements, and national biodefense strategies remain major demand anchors, while technological advantages such as faster development timelines, modular manufacturing, and strong IP protection support premium pricing and high margins. Growth is increasingly fueled by pipeline diversification (flu, RSV, combination vaccines, personalized cancer vaccines), improvements in lipid nanoparticle delivery and thermostability, and the build-out of regional manufacturing capacity to ensure supply security.
This report studies the global mRNA Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for mRNA Vaccines and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global mRNA Vaccines total production and demand, 2021-2032, (K Dose)
Global mRNA Vaccines total production value, 2021-2032, (USD Million)
Global mRNA Vaccines production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global mRNA Vaccines consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: mRNA Vaccines domestic production, consumption, key domestic manufacturers and share
Global mRNA Vaccines production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global mRNA Vaccines production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global mRNA Vaccines production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global mRNA Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, CureVac, Sanofi, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA immunotherapies, Ethris, Tiba Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global mRNA Vaccines Market, By Region:
1. How big is the global mRNA Vaccines market?
2. What is the demand of the global mRNA Vaccines market?
3. What is the year over year growth of the global mRNA Vaccines market?
4. What is the production and production value of the global mRNA Vaccines market?
5. Who are the key producers in the global mRNA Vaccines market?
6. What are the growth factors driving the market demand?
In 2025, global mRNA vaccine production was about 1.1 billion doses with capacity near 2 billion doses per year; the average revenue per dose is USD 8, and innovator gross margins are around 62%. mRNA vaccines are biologic medicines that use messenger RNA (mRNA) molecules to instruct human cells to produce a harmless piece of a pathogen (such as a viral spike protein), which triggers an immune response without exposing the body to the actual disease. Their supply chain spans multiple specialized layers: upstream raw materials (nucleotides, enzymes, plasmid DNA templates, lipid components for lipid nanoparticles, buffers, and sterile consumables), midstream manufacturing (in-vitro transcription of mRNA, purification, lipid nanoparticle encapsulation, sterile fill-finish, and cold-chain packaging), and downstream distribution and deployment (ultra-cold storage logistics, regulatory release, healthcare delivery, and post-market pharmacovigilance). The ecosystem involves biotech innovators, contract development and manufacturing organizations (CDMOs), lipid and reagent suppliers, cold-chain logistics providers, and healthcare systems, making mRNA vaccines a highly integrated biopharmaceutical supply chain driven by rapid scalability, advanced materials, and stringent quality control.
The mRNA vaccine market is driven by pandemic preparedness policies, rapid platform scalability, and expanding applications beyond infectious diseases into oncology and rare diseases. Government funding, advance purchase agreements, and national biodefense strategies remain major demand anchors, while technological advantages such as faster development timelines, modular manufacturing, and strong IP protection support premium pricing and high margins. Growth is increasingly fueled by pipeline diversification (flu, RSV, combination vaccines, personalized cancer vaccines), improvements in lipid nanoparticle delivery and thermostability, and the build-out of regional manufacturing capacity to ensure supply security.
This report studies the global mRNA Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for mRNA Vaccines and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global mRNA Vaccines total production and demand, 2021-2032, (K Dose)
Global mRNA Vaccines total production value, 2021-2032, (USD Million)
Global mRNA Vaccines production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global mRNA Vaccines consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: mRNA Vaccines domestic production, consumption, key domestic manufacturers and share
Global mRNA Vaccines production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global mRNA Vaccines production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global mRNA Vaccines production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global mRNA Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, CureVac, Sanofi, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA immunotherapies, Ethris, Tiba Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global mRNA Vaccines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Conventional mRNA
- Self-amplifying mRNA
- Trans-amplifying mRNA
- Circular mRNA
- Standard IVT Platform Vaccines
- Modular Platform Vaccines
- Lyophilized mRNA Vaccines
- Single-antigen Vaccines
- Multivalent Vaccines
- Personalized Vaccines
- Infectious Diseases
- Autoimmune Diseases
- Cancers
- Others
- Moderna
- CureVac
- Sanofi
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA immunotherapies
- Ethris
- Tiba Biotechnology
- Pfizer
- Arcturus Therapeutics
- Genexine
- Translate Bio
1. How big is the global mRNA Vaccines market?
2. What is the demand of the global mRNA Vaccines market?
3. What is the year over year growth of the global mRNA Vaccines market?
4. What is the production and production value of the global mRNA Vaccines market?
5. Who are the key producers in the global mRNA Vaccines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 mRNA Vaccines Introduction
1.2 World mRNA Vaccines Supply & Forecast
1.2.1 World mRNA Vaccines Production Value (2021 & 2025 & 2032)
1.2.2 World mRNA Vaccines Production (2021-2032)
1.2.3 World mRNA Vaccines Pricing Trends (2021-2032)
1.3 World mRNA Vaccines Production by Region (Based on Production Site)
1.3.1 World mRNA Vaccines Production Value by Region (2021-2032)
1.3.2 World mRNA Vaccines Production by Region (2021-2032)
1.3.3 World mRNA Vaccines Average Price by Region (2021-2032)
1.3.4 North America mRNA Vaccines Production (2021-2032)
1.3.5 Europe mRNA Vaccines Production (2021-2032)
1.3.6 China mRNA Vaccines Production (2021-2032)
1.3.7 Japan mRNA Vaccines Production (2021-2032)
1.3.8 India mRNA Vaccines Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Vaccines Major Market Trends
2 DEMAND SUMMARY
2.1 World mRNA Vaccines Demand (2021-2032)
2.2 World mRNA Vaccines Consumption by Region
2.2.1 World mRNA Vaccines Consumption by Region (2021-2026)
2.2.2 World mRNA Vaccines Consumption Forecast by Region (2027-2032)
2.3 United States mRNA Vaccines Consumption (2021-2032)
2.4 China mRNA Vaccines Consumption (2021-2032)
2.5 Europe mRNA Vaccines Consumption (2021-2032)
2.6 Japan mRNA Vaccines Consumption (2021-2032)
2.7 South Korea mRNA Vaccines Consumption (2021-2032)
2.8 ASEAN mRNA Vaccines Consumption (2021-2032)
2.9 India mRNA Vaccines Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World mRNA Vaccines Production Value by Manufacturer (2021-2026)
3.2 World mRNA Vaccines Production by Manufacturer (2021-2026)
3.3 World mRNA Vaccines Average Price by Manufacturer (2021-2026)
3.4 mRNA Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Vaccines in 2025
3.5.3 Global Concentration Ratios (CR8) for mRNA Vaccines in 2025
3.6 mRNA Vaccines Market: Overall Company Footprint Analysis
3.6.1 mRNA Vaccines Market: Region Footprint
3.6.2 mRNA Vaccines Market: Company Product Type Footprint
3.6.3 mRNA Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: mRNA Vaccines Production Value Comparison
4.1.1 United States VS China: mRNA Vaccines Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: mRNA Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: mRNA Vaccines Production Comparison
4.2.1 United States VS China: mRNA Vaccines Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: mRNA Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: mRNA Vaccines Consumption Comparison
4.3.1 United States VS China: mRNA Vaccines Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: mRNA Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based mRNA Vaccines Manufacturers and Market Share, 2021-2026
4.4.1 United States Based mRNA Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers mRNA Vaccines Production Value (2021-2026)
4.4.3 United States Based Manufacturers mRNA Vaccines Production (2021-2026)
4.5 China Based mRNA Vaccines Manufacturers and Market Share
4.5.1 China Based mRNA Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers mRNA Vaccines Production Value (2021-2026)
4.5.3 China Based Manufacturers mRNA Vaccines Production (2021-2026)
4.6 Rest of World Based mRNA Vaccines Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based mRNA Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers mRNA Vaccines Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers mRNA Vaccines Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World mRNA Vaccines Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Conventional mRNA
5.2.2 Self-amplifying mRNA
5.2.3 Trans-amplifying mRNA
5.2.4 Circular mRNA
5.3 Market Segment by Type
5.3.1 World mRNA Vaccines Production by Type (2021-2032)
5.3.2 World mRNA Vaccines Production Value by Type (2021-2032)
5.3.3 World mRNA Vaccines Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PLATFORM APPROACH
6.1 World mRNA Vaccines Market Size Overview by Platform Approach: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Platform Approach
6.2.1 Standard IVT Platform Vaccines
6.2.2 Modular Platform Vaccines
6.2.3 Lyophilized mRNA Vaccines
6.3 Market Segment by Platform Approach
6.3.1 World mRNA Vaccines Production by Platform Approach (2021-2032)
6.3.2 World mRNA Vaccines Production Value by Platform Approach (2021-2032)
6.3.3 World mRNA Vaccines Average Price by Platform Approach (2021-2032)
7 MARKET ANALYSIS BY ANTIGEN STRATEGY
7.1 World mRNA Vaccines Market Size Overview by Antigen Strategy: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Antigen Strategy
7.2.1 Single-antigen Vaccines
7.2.2 Multivalent Vaccines
7.2.3 Personalized Vaccines
7.3 Market Segment by Antigen Strategy
7.3.1 World mRNA Vaccines Production by Antigen Strategy (2021-2032)
7.3.2 World mRNA Vaccines Production Value by Antigen Strategy (2021-2032)
7.3.3 World mRNA Vaccines Average Price by Antigen Strategy (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World mRNA Vaccines Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Infectious Diseases
8.2.2 Autoimmune Diseases
8.2.3 Cancers
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World mRNA Vaccines Production by Application (2021-2032)
8.3.2 World mRNA Vaccines Production Value by Application (2021-2032)
8.3.3 World mRNA Vaccines Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Moderna
9.1.1 Moderna Details
9.1.2 Moderna Major Business
9.1.3 Moderna mRNA Vaccines Product and Services
9.1.4 Moderna mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Moderna Recent Developments/Updates
9.1.6 Moderna Competitive Strengths & Weaknesses
9.2 CureVac
9.2.1 CureVac Details
9.2.2 CureVac Major Business
9.2.3 CureVac mRNA Vaccines Product and Services
9.2.4 CureVac mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 CureVac Recent Developments/Updates
9.2.6 CureVac Competitive Strengths & Weaknesses
9.3 Sanofi
9.3.1 Sanofi Details
9.3.2 Sanofi Major Business
9.3.3 Sanofi mRNA Vaccines Product and Services
9.3.4 Sanofi mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Sanofi Recent Developments/Updates
9.3.6 Sanofi Competitive Strengths & Weaknesses
9.4 BioNTech
9.4.1 BioNTech Details
9.4.2 BioNTech Major Business
9.4.3 BioNTech mRNA Vaccines Product and Services
9.4.4 BioNTech mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 BioNTech Recent Developments/Updates
9.4.6 BioNTech Competitive Strengths & Weaknesses
9.5 Sangamo Therapeutics
9.5.1 Sangamo Therapeutics Details
9.5.2 Sangamo Therapeutics Major Business
9.5.3 Sangamo Therapeutics mRNA Vaccines Product and Services
9.5.4 Sangamo Therapeutics mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Sangamo Therapeutics Recent Developments/Updates
9.5.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
9.6 Argos Therapeutics
9.6.1 Argos Therapeutics Details
9.6.2 Argos Therapeutics Major Business
9.6.3 Argos Therapeutics mRNA Vaccines Product and Services
9.6.4 Argos Therapeutics mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Argos Therapeutics Recent Developments/Updates
9.6.6 Argos Therapeutics Competitive Strengths & Weaknesses
9.7 In-Cell-Art
9.7.1 In-Cell-Art Details
9.7.2 In-Cell-Art Major Business
9.7.3 In-Cell-Art mRNA Vaccines Product and Services
9.7.4 In-Cell-Art mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 In-Cell-Art Recent Developments/Updates
9.7.6 In-Cell-Art Competitive Strengths & Weaknesses
9.8 eTheRNA immunotherapies
9.8.1 eTheRNA immunotherapies Details
9.8.2 eTheRNA immunotherapies Major Business
9.8.3 eTheRNA immunotherapies mRNA Vaccines Product and Services
9.8.4 eTheRNA immunotherapies mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 eTheRNA immunotherapies Recent Developments/Updates
9.8.6 eTheRNA immunotherapies Competitive Strengths & Weaknesses
9.9 Ethris
9.9.1 Ethris Details
9.9.2 Ethris Major Business
9.9.3 Ethris mRNA Vaccines Product and Services
9.9.4 Ethris mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Ethris Recent Developments/Updates
9.9.6 Ethris Competitive Strengths & Weaknesses
9.10 Tiba Biotechnology
9.10.1 Tiba Biotechnology Details
9.10.2 Tiba Biotechnology Major Business
9.10.3 Tiba Biotechnology mRNA Vaccines Product and Services
9.10.4 Tiba Biotechnology mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Tiba Biotechnology Recent Developments/Updates
9.10.6 Tiba Biotechnology Competitive Strengths & Weaknesses
9.11 Pfizer
9.11.1 Pfizer Details
9.11.2 Pfizer Major Business
9.11.3 Pfizer mRNA Vaccines Product and Services
9.11.4 Pfizer mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Pfizer Recent Developments/Updates
9.11.6 Pfizer Competitive Strengths & Weaknesses
9.12 Arcturus Therapeutics
9.12.1 Arcturus Therapeutics Details
9.12.2 Arcturus Therapeutics Major Business
9.12.3 Arcturus Therapeutics mRNA Vaccines Product and Services
9.12.4 Arcturus Therapeutics mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Arcturus Therapeutics Recent Developments/Updates
9.12.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
9.13 Genexine
9.13.1 Genexine Details
9.13.2 Genexine Major Business
9.13.3 Genexine mRNA Vaccines Product and Services
9.13.4 Genexine mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Genexine Recent Developments/Updates
9.13.6 Genexine Competitive Strengths & Weaknesses
9.14 Translate Bio
9.14.1 Translate Bio Details
9.14.2 Translate Bio Major Business
9.14.3 Translate Bio mRNA Vaccines Product and Services
9.14.4 Translate Bio mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Translate Bio Recent Developments/Updates
9.14.6 Translate Bio Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 mRNA Vaccines Industry Chain
10.2 mRNA Vaccines Upstream Analysis
10.2.1 mRNA Vaccines Core Raw Materials
10.2.2 Main Manufacturers of mRNA Vaccines Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 mRNA Vaccines Production Mode
10.6 mRNA Vaccines Procurement Model
10.7 mRNA Vaccines Industry Sales Model and Sales Channels
10.7.1 mRNA Vaccines Sales Model
10.7.2 mRNA Vaccines Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 mRNA Vaccines Introduction
1.2 World mRNA Vaccines Supply & Forecast
1.2.1 World mRNA Vaccines Production Value (2021 & 2025 & 2032)
1.2.2 World mRNA Vaccines Production (2021-2032)
1.2.3 World mRNA Vaccines Pricing Trends (2021-2032)
1.3 World mRNA Vaccines Production by Region (Based on Production Site)
1.3.1 World mRNA Vaccines Production Value by Region (2021-2032)
1.3.2 World mRNA Vaccines Production by Region (2021-2032)
1.3.3 World mRNA Vaccines Average Price by Region (2021-2032)
1.3.4 North America mRNA Vaccines Production (2021-2032)
1.3.5 Europe mRNA Vaccines Production (2021-2032)
1.3.6 China mRNA Vaccines Production (2021-2032)
1.3.7 Japan mRNA Vaccines Production (2021-2032)
1.3.8 India mRNA Vaccines Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Vaccines Major Market Trends
2 DEMAND SUMMARY
2.1 World mRNA Vaccines Demand (2021-2032)
2.2 World mRNA Vaccines Consumption by Region
2.2.1 World mRNA Vaccines Consumption by Region (2021-2026)
2.2.2 World mRNA Vaccines Consumption Forecast by Region (2027-2032)
2.3 United States mRNA Vaccines Consumption (2021-2032)
2.4 China mRNA Vaccines Consumption (2021-2032)
2.5 Europe mRNA Vaccines Consumption (2021-2032)
2.6 Japan mRNA Vaccines Consumption (2021-2032)
2.7 South Korea mRNA Vaccines Consumption (2021-2032)
2.8 ASEAN mRNA Vaccines Consumption (2021-2032)
2.9 India mRNA Vaccines Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World mRNA Vaccines Production Value by Manufacturer (2021-2026)
3.2 World mRNA Vaccines Production by Manufacturer (2021-2026)
3.3 World mRNA Vaccines Average Price by Manufacturer (2021-2026)
3.4 mRNA Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Vaccines in 2025
3.5.3 Global Concentration Ratios (CR8) for mRNA Vaccines in 2025
3.6 mRNA Vaccines Market: Overall Company Footprint Analysis
3.6.1 mRNA Vaccines Market: Region Footprint
3.6.2 mRNA Vaccines Market: Company Product Type Footprint
3.6.3 mRNA Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: mRNA Vaccines Production Value Comparison
4.1.1 United States VS China: mRNA Vaccines Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: mRNA Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: mRNA Vaccines Production Comparison
4.2.1 United States VS China: mRNA Vaccines Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: mRNA Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: mRNA Vaccines Consumption Comparison
4.3.1 United States VS China: mRNA Vaccines Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: mRNA Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based mRNA Vaccines Manufacturers and Market Share, 2021-2026
4.4.1 United States Based mRNA Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers mRNA Vaccines Production Value (2021-2026)
4.4.3 United States Based Manufacturers mRNA Vaccines Production (2021-2026)
4.5 China Based mRNA Vaccines Manufacturers and Market Share
4.5.1 China Based mRNA Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers mRNA Vaccines Production Value (2021-2026)
4.5.3 China Based Manufacturers mRNA Vaccines Production (2021-2026)
4.6 Rest of World Based mRNA Vaccines Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based mRNA Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers mRNA Vaccines Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers mRNA Vaccines Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World mRNA Vaccines Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Conventional mRNA
5.2.2 Self-amplifying mRNA
5.2.3 Trans-amplifying mRNA
5.2.4 Circular mRNA
5.3 Market Segment by Type
5.3.1 World mRNA Vaccines Production by Type (2021-2032)
5.3.2 World mRNA Vaccines Production Value by Type (2021-2032)
5.3.3 World mRNA Vaccines Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PLATFORM APPROACH
6.1 World mRNA Vaccines Market Size Overview by Platform Approach: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Platform Approach
6.2.1 Standard IVT Platform Vaccines
6.2.2 Modular Platform Vaccines
6.2.3 Lyophilized mRNA Vaccines
6.3 Market Segment by Platform Approach
6.3.1 World mRNA Vaccines Production by Platform Approach (2021-2032)
6.3.2 World mRNA Vaccines Production Value by Platform Approach (2021-2032)
6.3.3 World mRNA Vaccines Average Price by Platform Approach (2021-2032)
7 MARKET ANALYSIS BY ANTIGEN STRATEGY
7.1 World mRNA Vaccines Market Size Overview by Antigen Strategy: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Antigen Strategy
7.2.1 Single-antigen Vaccines
7.2.2 Multivalent Vaccines
7.2.3 Personalized Vaccines
7.3 Market Segment by Antigen Strategy
7.3.1 World mRNA Vaccines Production by Antigen Strategy (2021-2032)
7.3.2 World mRNA Vaccines Production Value by Antigen Strategy (2021-2032)
7.3.3 World mRNA Vaccines Average Price by Antigen Strategy (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World mRNA Vaccines Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Infectious Diseases
8.2.2 Autoimmune Diseases
8.2.3 Cancers
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World mRNA Vaccines Production by Application (2021-2032)
8.3.2 World mRNA Vaccines Production Value by Application (2021-2032)
8.3.3 World mRNA Vaccines Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Moderna
9.1.1 Moderna Details
9.1.2 Moderna Major Business
9.1.3 Moderna mRNA Vaccines Product and Services
9.1.4 Moderna mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Moderna Recent Developments/Updates
9.1.6 Moderna Competitive Strengths & Weaknesses
9.2 CureVac
9.2.1 CureVac Details
9.2.2 CureVac Major Business
9.2.3 CureVac mRNA Vaccines Product and Services
9.2.4 CureVac mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 CureVac Recent Developments/Updates
9.2.6 CureVac Competitive Strengths & Weaknesses
9.3 Sanofi
9.3.1 Sanofi Details
9.3.2 Sanofi Major Business
9.3.3 Sanofi mRNA Vaccines Product and Services
9.3.4 Sanofi mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Sanofi Recent Developments/Updates
9.3.6 Sanofi Competitive Strengths & Weaknesses
9.4 BioNTech
9.4.1 BioNTech Details
9.4.2 BioNTech Major Business
9.4.3 BioNTech mRNA Vaccines Product and Services
9.4.4 BioNTech mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 BioNTech Recent Developments/Updates
9.4.6 BioNTech Competitive Strengths & Weaknesses
9.5 Sangamo Therapeutics
9.5.1 Sangamo Therapeutics Details
9.5.2 Sangamo Therapeutics Major Business
9.5.3 Sangamo Therapeutics mRNA Vaccines Product and Services
9.5.4 Sangamo Therapeutics mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Sangamo Therapeutics Recent Developments/Updates
9.5.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
9.6 Argos Therapeutics
9.6.1 Argos Therapeutics Details
9.6.2 Argos Therapeutics Major Business
9.6.3 Argos Therapeutics mRNA Vaccines Product and Services
9.6.4 Argos Therapeutics mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Argos Therapeutics Recent Developments/Updates
9.6.6 Argos Therapeutics Competitive Strengths & Weaknesses
9.7 In-Cell-Art
9.7.1 In-Cell-Art Details
9.7.2 In-Cell-Art Major Business
9.7.3 In-Cell-Art mRNA Vaccines Product and Services
9.7.4 In-Cell-Art mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 In-Cell-Art Recent Developments/Updates
9.7.6 In-Cell-Art Competitive Strengths & Weaknesses
9.8 eTheRNA immunotherapies
9.8.1 eTheRNA immunotherapies Details
9.8.2 eTheRNA immunotherapies Major Business
9.8.3 eTheRNA immunotherapies mRNA Vaccines Product and Services
9.8.4 eTheRNA immunotherapies mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 eTheRNA immunotherapies Recent Developments/Updates
9.8.6 eTheRNA immunotherapies Competitive Strengths & Weaknesses
9.9 Ethris
9.9.1 Ethris Details
9.9.2 Ethris Major Business
9.9.3 Ethris mRNA Vaccines Product and Services
9.9.4 Ethris mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Ethris Recent Developments/Updates
9.9.6 Ethris Competitive Strengths & Weaknesses
9.10 Tiba Biotechnology
9.10.1 Tiba Biotechnology Details
9.10.2 Tiba Biotechnology Major Business
9.10.3 Tiba Biotechnology mRNA Vaccines Product and Services
9.10.4 Tiba Biotechnology mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Tiba Biotechnology Recent Developments/Updates
9.10.6 Tiba Biotechnology Competitive Strengths & Weaknesses
9.11 Pfizer
9.11.1 Pfizer Details
9.11.2 Pfizer Major Business
9.11.3 Pfizer mRNA Vaccines Product and Services
9.11.4 Pfizer mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Pfizer Recent Developments/Updates
9.11.6 Pfizer Competitive Strengths & Weaknesses
9.12 Arcturus Therapeutics
9.12.1 Arcturus Therapeutics Details
9.12.2 Arcturus Therapeutics Major Business
9.12.3 Arcturus Therapeutics mRNA Vaccines Product and Services
9.12.4 Arcturus Therapeutics mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Arcturus Therapeutics Recent Developments/Updates
9.12.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
9.13 Genexine
9.13.1 Genexine Details
9.13.2 Genexine Major Business
9.13.3 Genexine mRNA Vaccines Product and Services
9.13.4 Genexine mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Genexine Recent Developments/Updates
9.13.6 Genexine Competitive Strengths & Weaknesses
9.14 Translate Bio
9.14.1 Translate Bio Details
9.14.2 Translate Bio Major Business
9.14.3 Translate Bio mRNA Vaccines Product and Services
9.14.4 Translate Bio mRNA Vaccines Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Translate Bio Recent Developments/Updates
9.14.6 Translate Bio Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 mRNA Vaccines Industry Chain
10.2 mRNA Vaccines Upstream Analysis
10.2.1 mRNA Vaccines Core Raw Materials
10.2.2 Main Manufacturers of mRNA Vaccines Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 mRNA Vaccines Production Mode
10.6 mRNA Vaccines Procurement Model
10.7 mRNA Vaccines Industry Sales Model and Sales Channels
10.7.1 mRNA Vaccines Sales Model
10.7.2 mRNA Vaccines Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World mRNA Vaccines Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World mRNA Vaccines Production Value by Region (2021-2026) & (USD Million)
Table 3. World mRNA Vaccines Production Value by Region (2027-2032) & (USD Million)
Table 4. World mRNA Vaccines Production Value Market Share by Region (2021-2026)
Table 5. World mRNA Vaccines Production Value Market Share by Region (2027-2032)
Table 6. World mRNA Vaccines Production by Region (2021-2026) & (K Dose)
Table 7. World mRNA Vaccines Production by Region (2027-2032) & (K Dose)
Table 8. World mRNA Vaccines Production Market Share by Region (2021-2026)
Table 9. World mRNA Vaccines Production Market Share by Region (2027-2032)
Table 10. World mRNA Vaccines Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World mRNA Vaccines Average Price by Region (2027-2032) & (US$/Dose)
Table 12. mRNA Vaccines Major Market Trends
Table 13. World mRNA Vaccines Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World mRNA Vaccines Consumption by Region (2021-2026) & (K Dose)
Table 15. World mRNA Vaccines Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World mRNA Vaccines Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Vaccines Producers in 2025
Table 18. World mRNA Vaccines Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key mRNA Vaccines Producers in 2025
Table 20. World mRNA Vaccines Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global mRNA Vaccines Company Evaluation Quadrant
Table 22. World mRNA Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and mRNA Vaccines Production Site of Key Manufacturer
Table 24. mRNA Vaccines Market: Company Product Type Footprint
Table 25. mRNA Vaccines Market: Company Product Application Footprint
Table 26. mRNA Vaccines Competitive Factors
Table 27. mRNA Vaccines New Entrant and Capacity Expansion Plans
Table 28. mRNA Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Vaccines Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China mRNA Vaccines Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China mRNA Vaccines Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based mRNA Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers mRNA Vaccines Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers mRNA Vaccines Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers mRNA Vaccines Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers mRNA Vaccines Production Market Share (2021-2026)
Table 37. China Based mRNA Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers mRNA Vaccines Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers mRNA Vaccines Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers mRNA Vaccines Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers mRNA Vaccines Production Market Share (2021-2026)
Table 42. Rest of World Based mRNA Vaccines Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers mRNA Vaccines Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers mRNA Vaccines Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers mRNA Vaccines Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers mRNA Vaccines Production Market Share (2021-2026)
Table 47. World mRNA Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World mRNA Vaccines Production by Type (2021-2026) & (K Dose)
Table 49. World mRNA Vaccines Production by Type (2027-2032) & (K Dose)
Table 50. World mRNA Vaccines Production Value by Type (2021-2026) & (USD Million)
Table 51. World mRNA Vaccines Production Value by Type (2027-2032) & (USD Million)
Table 52. World mRNA Vaccines Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World mRNA Vaccines Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World mRNA Vaccines Production Value by Platform Approach, (USD Million), 2021 & 2025 & 2032
Table 55. World mRNA Vaccines Production by Platform Approach (2021-2026) & (K Dose)
Table 56. World mRNA Vaccines Production by Platform Approach (2027-2032) & (K Dose)
Table 57. World mRNA Vaccines Production Value by Platform Approach (2021-2026) & (USD Million)
Table 58. World mRNA Vaccines Production Value by Platform Approach (2027-2032) & (USD Million)
Table 59. World mRNA Vaccines Average Price by Platform Approach (2021-2026) & (US$/Dose)
Table 60. World mRNA Vaccines Average Price by Platform Approach (2027-2032) & (US$/Dose)
Table 61. World mRNA Vaccines Production Value by Antigen Strategy, (USD Million), 2021 & 2025 & 2032
Table 62. World mRNA Vaccines Production by Antigen Strategy (2021-2026) & (K Dose)
Table 63. World mRNA Vaccines Production by Antigen Strategy (2027-2032) & (K Dose)
Table 64. World mRNA Vaccines Production Value by Antigen Strategy (2021-2026) & (USD Million)
Table 65. World mRNA Vaccines Production Value by Antigen Strategy (2027-2032) & (USD Million)
Table 66. World mRNA Vaccines Average Price by Antigen Strategy (2021-2026) & (US$/Dose)
Table 67. World mRNA Vaccines Average Price by Antigen Strategy (2027-2032) & (US$/Dose)
Table 68. World mRNA Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World mRNA Vaccines Production by Application (2021-2026) & (K Dose)
Table 70. World mRNA Vaccines Production by Application (2027-2032) & (K Dose)
Table 71. World mRNA Vaccines Production Value by Application (2021-2026) & (USD Million)
Table 72. World mRNA Vaccines Production Value by Application (2027-2032) & (USD Million)
Table 73. World mRNA Vaccines Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World mRNA Vaccines Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Moderna Basic Information, Manufacturing Base and Competitors
Table 76. Moderna Major Business
Table 77. Moderna mRNA Vaccines Product and Services
Table 78. Moderna mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Moderna Recent Developments/Updates
Table 80. Moderna Competitive Strengths & Weaknesses
Table 81. CureVac Basic Information, Manufacturing Base and Competitors
Table 82. CureVac Major Business
Table 83. CureVac mRNA Vaccines Product and Services
Table 84. CureVac mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. CureVac Recent Developments/Updates
Table 86. CureVac Competitive Strengths & Weaknesses
Table 87. Sanofi Basic Information, Manufacturing Base and Competitors
Table 88. Sanofi Major Business
Table 89. Sanofi mRNA Vaccines Product and Services
Table 90. Sanofi mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Sanofi Recent Developments/Updates
Table 92. Sanofi Competitive Strengths & Weaknesses
Table 93. BioNTech Basic Information, Manufacturing Base and Competitors
Table 94. BioNTech Major Business
Table 95. BioNTech mRNA Vaccines Product and Services
Table 96. BioNTech mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. BioNTech Recent Developments/Updates
Table 98. BioNTech Competitive Strengths & Weaknesses
Table 99. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 100. Sangamo Therapeutics Major Business
Table 101. Sangamo Therapeutics mRNA Vaccines Product and Services
Table 102. Sangamo Therapeutics mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Sangamo Therapeutics Recent Developments/Updates
Table 104. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 105. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 106. Argos Therapeutics Major Business
Table 107. Argos Therapeutics mRNA Vaccines Product and Services
Table 108. Argos Therapeutics mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Argos Therapeutics Recent Developments/Updates
Table 110. Argos Therapeutics Competitive Strengths & Weaknesses
Table 111. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 112. In-Cell-Art Major Business
Table 113. In-Cell-Art mRNA Vaccines Product and Services
Table 114. In-Cell-Art mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. In-Cell-Art Recent Developments/Updates
Table 116. In-Cell-Art Competitive Strengths & Weaknesses
Table 117. eTheRNA immunotherapies Basic Information, Manufacturing Base and Competitors
Table 118. eTheRNA immunotherapies Major Business
Table 119. eTheRNA immunotherapies mRNA Vaccines Product and Services
Table 120. eTheRNA immunotherapies mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. eTheRNA immunotherapies Recent Developments/Updates
Table 122. eTheRNA immunotherapies Competitive Strengths & Weaknesses
Table 123. Ethris Basic Information, Manufacturing Base and Competitors
Table 124. Ethris Major Business
Table 125. Ethris mRNA Vaccines Product and Services
Table 126. Ethris mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Ethris Recent Developments/Updates
Table 128. Ethris Competitive Strengths & Weaknesses
Table 129. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 130. Tiba Biotechnology Major Business
Table 131. Tiba Biotechnology mRNA Vaccines Product and Services
Table 132. Tiba Biotechnology mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Tiba Biotechnology Recent Developments/Updates
Table 134. Tiba Biotechnology Competitive Strengths & Weaknesses
Table 135. Pfizer Basic Information, Manufacturing Base and Competitors
Table 136. Pfizer Major Business
Table 137. Pfizer mRNA Vaccines Product and Services
Table 138. Pfizer mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Pfizer Recent Developments/Updates
Table 140. Pfizer Competitive Strengths & Weaknesses
Table 141. Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 142. Arcturus Therapeutics Major Business
Table 143. Arcturus Therapeutics mRNA Vaccines Product and Services
Table 144. Arcturus Therapeutics mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Arcturus Therapeutics Recent Developments/Updates
Table 146. Arcturus Therapeutics Competitive Strengths & Weaknesses
Table 147. Genexine Basic Information, Manufacturing Base and Competitors
Table 148. Genexine Major Business
Table 149. Genexine mRNA Vaccines Product and Services
Table 150. Genexine mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Genexine Recent Developments/Updates
Table 152. Genexine Competitive Strengths & Weaknesses
Table 153. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 154. Translate Bio Major Business
Table 155. Translate Bio mRNA Vaccines Product and Services
Table 156. Translate Bio mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Translate Bio Recent Developments/Updates
Table 158. Translate Bio Competitive Strengths & Weaknesses
Table 159. Global Key Players of mRNA Vaccines Upstream (Raw Materials)
Table 160. Global mRNA Vaccines Typical Customers
Table 161. mRNA Vaccines Typical Distributors
Table 1. World mRNA Vaccines Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World mRNA Vaccines Production Value by Region (2021-2026) & (USD Million)
Table 3. World mRNA Vaccines Production Value by Region (2027-2032) & (USD Million)
Table 4. World mRNA Vaccines Production Value Market Share by Region (2021-2026)
Table 5. World mRNA Vaccines Production Value Market Share by Region (2027-2032)
Table 6. World mRNA Vaccines Production by Region (2021-2026) & (K Dose)
Table 7. World mRNA Vaccines Production by Region (2027-2032) & (K Dose)
Table 8. World mRNA Vaccines Production Market Share by Region (2021-2026)
Table 9. World mRNA Vaccines Production Market Share by Region (2027-2032)
Table 10. World mRNA Vaccines Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World mRNA Vaccines Average Price by Region (2027-2032) & (US$/Dose)
Table 12. mRNA Vaccines Major Market Trends
Table 13. World mRNA Vaccines Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World mRNA Vaccines Consumption by Region (2021-2026) & (K Dose)
Table 15. World mRNA Vaccines Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World mRNA Vaccines Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Vaccines Producers in 2025
Table 18. World mRNA Vaccines Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key mRNA Vaccines Producers in 2025
Table 20. World mRNA Vaccines Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global mRNA Vaccines Company Evaluation Quadrant
Table 22. World mRNA Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and mRNA Vaccines Production Site of Key Manufacturer
Table 24. mRNA Vaccines Market: Company Product Type Footprint
Table 25. mRNA Vaccines Market: Company Product Application Footprint
Table 26. mRNA Vaccines Competitive Factors
Table 27. mRNA Vaccines New Entrant and Capacity Expansion Plans
Table 28. mRNA Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Vaccines Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China mRNA Vaccines Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China mRNA Vaccines Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based mRNA Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers mRNA Vaccines Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers mRNA Vaccines Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers mRNA Vaccines Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers mRNA Vaccines Production Market Share (2021-2026)
Table 37. China Based mRNA Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers mRNA Vaccines Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers mRNA Vaccines Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers mRNA Vaccines Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers mRNA Vaccines Production Market Share (2021-2026)
Table 42. Rest of World Based mRNA Vaccines Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers mRNA Vaccines Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers mRNA Vaccines Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers mRNA Vaccines Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers mRNA Vaccines Production Market Share (2021-2026)
Table 47. World mRNA Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World mRNA Vaccines Production by Type (2021-2026) & (K Dose)
Table 49. World mRNA Vaccines Production by Type (2027-2032) & (K Dose)
Table 50. World mRNA Vaccines Production Value by Type (2021-2026) & (USD Million)
Table 51. World mRNA Vaccines Production Value by Type (2027-2032) & (USD Million)
Table 52. World mRNA Vaccines Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World mRNA Vaccines Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World mRNA Vaccines Production Value by Platform Approach, (USD Million), 2021 & 2025 & 2032
Table 55. World mRNA Vaccines Production by Platform Approach (2021-2026) & (K Dose)
Table 56. World mRNA Vaccines Production by Platform Approach (2027-2032) & (K Dose)
Table 57. World mRNA Vaccines Production Value by Platform Approach (2021-2026) & (USD Million)
Table 58. World mRNA Vaccines Production Value by Platform Approach (2027-2032) & (USD Million)
Table 59. World mRNA Vaccines Average Price by Platform Approach (2021-2026) & (US$/Dose)
Table 60. World mRNA Vaccines Average Price by Platform Approach (2027-2032) & (US$/Dose)
Table 61. World mRNA Vaccines Production Value by Antigen Strategy, (USD Million), 2021 & 2025 & 2032
Table 62. World mRNA Vaccines Production by Antigen Strategy (2021-2026) & (K Dose)
Table 63. World mRNA Vaccines Production by Antigen Strategy (2027-2032) & (K Dose)
Table 64. World mRNA Vaccines Production Value by Antigen Strategy (2021-2026) & (USD Million)
Table 65. World mRNA Vaccines Production Value by Antigen Strategy (2027-2032) & (USD Million)
Table 66. World mRNA Vaccines Average Price by Antigen Strategy (2021-2026) & (US$/Dose)
Table 67. World mRNA Vaccines Average Price by Antigen Strategy (2027-2032) & (US$/Dose)
Table 68. World mRNA Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World mRNA Vaccines Production by Application (2021-2026) & (K Dose)
Table 70. World mRNA Vaccines Production by Application (2027-2032) & (K Dose)
Table 71. World mRNA Vaccines Production Value by Application (2021-2026) & (USD Million)
Table 72. World mRNA Vaccines Production Value by Application (2027-2032) & (USD Million)
Table 73. World mRNA Vaccines Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World mRNA Vaccines Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Moderna Basic Information, Manufacturing Base and Competitors
Table 76. Moderna Major Business
Table 77. Moderna mRNA Vaccines Product and Services
Table 78. Moderna mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Moderna Recent Developments/Updates
Table 80. Moderna Competitive Strengths & Weaknesses
Table 81. CureVac Basic Information, Manufacturing Base and Competitors
Table 82. CureVac Major Business
Table 83. CureVac mRNA Vaccines Product and Services
Table 84. CureVac mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. CureVac Recent Developments/Updates
Table 86. CureVac Competitive Strengths & Weaknesses
Table 87. Sanofi Basic Information, Manufacturing Base and Competitors
Table 88. Sanofi Major Business
Table 89. Sanofi mRNA Vaccines Product and Services
Table 90. Sanofi mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Sanofi Recent Developments/Updates
Table 92. Sanofi Competitive Strengths & Weaknesses
Table 93. BioNTech Basic Information, Manufacturing Base and Competitors
Table 94. BioNTech Major Business
Table 95. BioNTech mRNA Vaccines Product and Services
Table 96. BioNTech mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. BioNTech Recent Developments/Updates
Table 98. BioNTech Competitive Strengths & Weaknesses
Table 99. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 100. Sangamo Therapeutics Major Business
Table 101. Sangamo Therapeutics mRNA Vaccines Product and Services
Table 102. Sangamo Therapeutics mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Sangamo Therapeutics Recent Developments/Updates
Table 104. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 105. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 106. Argos Therapeutics Major Business
Table 107. Argos Therapeutics mRNA Vaccines Product and Services
Table 108. Argos Therapeutics mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Argos Therapeutics Recent Developments/Updates
Table 110. Argos Therapeutics Competitive Strengths & Weaknesses
Table 111. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 112. In-Cell-Art Major Business
Table 113. In-Cell-Art mRNA Vaccines Product and Services
Table 114. In-Cell-Art mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. In-Cell-Art Recent Developments/Updates
Table 116. In-Cell-Art Competitive Strengths & Weaknesses
Table 117. eTheRNA immunotherapies Basic Information, Manufacturing Base and Competitors
Table 118. eTheRNA immunotherapies Major Business
Table 119. eTheRNA immunotherapies mRNA Vaccines Product and Services
Table 120. eTheRNA immunotherapies mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. eTheRNA immunotherapies Recent Developments/Updates
Table 122. eTheRNA immunotherapies Competitive Strengths & Weaknesses
Table 123. Ethris Basic Information, Manufacturing Base and Competitors
Table 124. Ethris Major Business
Table 125. Ethris mRNA Vaccines Product and Services
Table 126. Ethris mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Ethris Recent Developments/Updates
Table 128. Ethris Competitive Strengths & Weaknesses
Table 129. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 130. Tiba Biotechnology Major Business
Table 131. Tiba Biotechnology mRNA Vaccines Product and Services
Table 132. Tiba Biotechnology mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Tiba Biotechnology Recent Developments/Updates
Table 134. Tiba Biotechnology Competitive Strengths & Weaknesses
Table 135. Pfizer Basic Information, Manufacturing Base and Competitors
Table 136. Pfizer Major Business
Table 137. Pfizer mRNA Vaccines Product and Services
Table 138. Pfizer mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Pfizer Recent Developments/Updates
Table 140. Pfizer Competitive Strengths & Weaknesses
Table 141. Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 142. Arcturus Therapeutics Major Business
Table 143. Arcturus Therapeutics mRNA Vaccines Product and Services
Table 144. Arcturus Therapeutics mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Arcturus Therapeutics Recent Developments/Updates
Table 146. Arcturus Therapeutics Competitive Strengths & Weaknesses
Table 147. Genexine Basic Information, Manufacturing Base and Competitors
Table 148. Genexine Major Business
Table 149. Genexine mRNA Vaccines Product and Services
Table 150. Genexine mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Genexine Recent Developments/Updates
Table 152. Genexine Competitive Strengths & Weaknesses
Table 153. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 154. Translate Bio Major Business
Table 155. Translate Bio mRNA Vaccines Product and Services
Table 156. Translate Bio mRNA Vaccines Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Translate Bio Recent Developments/Updates
Table 158. Translate Bio Competitive Strengths & Weaknesses
Table 159. Global Key Players of mRNA Vaccines Upstream (Raw Materials)
Table 160. Global mRNA Vaccines Typical Customers
Table 161. mRNA Vaccines Typical Distributors
LIST OF FIGURES
Figure 1. mRNA Vaccines Picture
Figure 2. World mRNA Vaccines Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World mRNA Vaccines Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 5. World mRNA Vaccines Average Price (2021-2032) & (US$/Dose)
Figure 6. World mRNA Vaccines Production Value Market Share by Region (2021-2032)
Figure 7. World mRNA Vaccines Production Market Share by Region (2021-2032)
Figure 8. North America mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 9. Europe mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 10. China mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 11. Japan mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 12. India mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 13. mRNA Vaccines Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 16. World mRNA Vaccines Consumption Market Share by Region (2021-2032)
Figure 17. United States mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 18. China mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 19. Europe mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 20. Japan mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 21. South Korea mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 23. India mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of mRNA Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for mRNA Vaccines Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for mRNA Vaccines Markets in 2025
Figure 27. United States VS China: mRNA Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: mRNA Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: mRNA Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers mRNA Vaccines Production Market Share 2025
Figure 31. China Based Manufacturers mRNA Vaccines Production Market Share 2025
Figure 32. Rest of World Based Manufacturers mRNA Vaccines Production Market Share 2025
Figure 33. World mRNA Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World mRNA Vaccines Production Value Market Share by Type in 2025
Figure 35. Conventional mRNA
Figure 36. Self-amplifying mRNA
Figure 37. Trans-amplifying mRNA
Figure 38. Circular mRNA
Figure 39. World mRNA Vaccines Production Market Share by Type (2021-2032)
Figure 40. World mRNA Vaccines Production Value Market Share by Type (2021-2032)
Figure 41. World mRNA Vaccines Average Price by Type (2021-2032) & (US$/Dose)
Figure 42. World mRNA Vaccines Production Value by Platform Approach, (USD Million), 2021 & 2025 & 2032
Figure 43. World mRNA Vaccines Production Value Market Share by Platform Approach in 2025
Figure 44. Standard IVT Platform Vaccines
Figure 45. Modular Platform Vaccines
Figure 46. Lyophilized mRNA Vaccines
Figure 47. World mRNA Vaccines Production Market Share by Platform Approach (2021-2032)
Figure 48. World mRNA Vaccines Production Value Market Share by Platform Approach (2021-2032)
Figure 49. World mRNA Vaccines Average Price by Platform Approach (2021-2032) & (US$/Dose)
Figure 50. World mRNA Vaccines Production Value by Antigen Strategy, (USD Million), 2021 & 2025 & 2032
Figure 51. World mRNA Vaccines Production Value Market Share by Antigen Strategy in 2025
Figure 52. Single-antigen Vaccines
Figure 53. Multivalent Vaccines
Figure 54. Personalized Vaccines
Figure 55. World mRNA Vaccines Production Market Share by Antigen Strategy (2021-2032)
Figure 56. World mRNA Vaccines Production Value Market Share by Antigen Strategy (2021-2032)
Figure 57. World mRNA Vaccines Average Price by Antigen Strategy (2021-2032) & (US$/Dose)
Figure 58. World mRNA Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World mRNA Vaccines Production Value Market Share by Application in 2025
Figure 60. Infectious Diseases
Figure 61. Autoimmune Diseases
Figure 62. Cancers
Figure 63. Others
Figure 64. World mRNA Vaccines Production Market Share by Application (2021-2032)
Figure 65. World mRNA Vaccines Production Value Market Share by Application (2021-2032)
Figure 66. World mRNA Vaccines Average Price by Application (2021-2032) & (US$/Dose)
Figure 67. mRNA Vaccines Industry Chain
Figure 68. mRNA Vaccines Procurement Model
Figure 69. mRNA Vaccines Sales Model
Figure 70. mRNA Vaccines Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. mRNA Vaccines Picture
Figure 2. World mRNA Vaccines Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World mRNA Vaccines Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 5. World mRNA Vaccines Average Price (2021-2032) & (US$/Dose)
Figure 6. World mRNA Vaccines Production Value Market Share by Region (2021-2032)
Figure 7. World mRNA Vaccines Production Market Share by Region (2021-2032)
Figure 8. North America mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 9. Europe mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 10. China mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 11. Japan mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 12. India mRNA Vaccines Production (2021-2032) & (K Dose)
Figure 13. mRNA Vaccines Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 16. World mRNA Vaccines Consumption Market Share by Region (2021-2032)
Figure 17. United States mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 18. China mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 19. Europe mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 20. Japan mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 21. South Korea mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 23. India mRNA Vaccines Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of mRNA Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for mRNA Vaccines Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for mRNA Vaccines Markets in 2025
Figure 27. United States VS China: mRNA Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: mRNA Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: mRNA Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers mRNA Vaccines Production Market Share 2025
Figure 31. China Based Manufacturers mRNA Vaccines Production Market Share 2025
Figure 32. Rest of World Based Manufacturers mRNA Vaccines Production Market Share 2025
Figure 33. World mRNA Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World mRNA Vaccines Production Value Market Share by Type in 2025
Figure 35. Conventional mRNA
Figure 36. Self-amplifying mRNA
Figure 37. Trans-amplifying mRNA
Figure 38. Circular mRNA
Figure 39. World mRNA Vaccines Production Market Share by Type (2021-2032)
Figure 40. World mRNA Vaccines Production Value Market Share by Type (2021-2032)
Figure 41. World mRNA Vaccines Average Price by Type (2021-2032) & (US$/Dose)
Figure 42. World mRNA Vaccines Production Value by Platform Approach, (USD Million), 2021 & 2025 & 2032
Figure 43. World mRNA Vaccines Production Value Market Share by Platform Approach in 2025
Figure 44. Standard IVT Platform Vaccines
Figure 45. Modular Platform Vaccines
Figure 46. Lyophilized mRNA Vaccines
Figure 47. World mRNA Vaccines Production Market Share by Platform Approach (2021-2032)
Figure 48. World mRNA Vaccines Production Value Market Share by Platform Approach (2021-2032)
Figure 49. World mRNA Vaccines Average Price by Platform Approach (2021-2032) & (US$/Dose)
Figure 50. World mRNA Vaccines Production Value by Antigen Strategy, (USD Million), 2021 & 2025 & 2032
Figure 51. World mRNA Vaccines Production Value Market Share by Antigen Strategy in 2025
Figure 52. Single-antigen Vaccines
Figure 53. Multivalent Vaccines
Figure 54. Personalized Vaccines
Figure 55. World mRNA Vaccines Production Market Share by Antigen Strategy (2021-2032)
Figure 56. World mRNA Vaccines Production Value Market Share by Antigen Strategy (2021-2032)
Figure 57. World mRNA Vaccines Average Price by Antigen Strategy (2021-2032) & (US$/Dose)
Figure 58. World mRNA Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World mRNA Vaccines Production Value Market Share by Application in 2025
Figure 60. Infectious Diseases
Figure 61. Autoimmune Diseases
Figure 62. Cancers
Figure 63. Others
Figure 64. World mRNA Vaccines Production Market Share by Application (2021-2032)
Figure 65. World mRNA Vaccines Production Value Market Share by Application (2021-2032)
Figure 66. World mRNA Vaccines Average Price by Application (2021-2032) & (US$/Dose)
Figure 67. mRNA Vaccines Industry Chain
Figure 68. mRNA Vaccines Procurement Model
Figure 69. mRNA Vaccines Sales Model
Figure 70. mRNA Vaccines Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
